Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a half-life of up to 60 hours, and superior pharmacokinetic properties compared to ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Josh Gad says he's taking 'life-changing' GLP-1 medication for weight loss but admits that it can't replace having a healthy ...

But while the clinic staff wrestles with the insurance companies, physicians can still work with patients ... “We should look at GLP-1 receptor agonists as cardiovascular risk-reducing ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

In conclusion, hope for more efficient, individualized, and secure therapies may come from continuing research and breakthroughs in novel diabetes treatment targets. These developments are at the ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a ...

From Ozempic butt to Ozempic for kids, semaglutide drugs are everywhere causing a whole host of concerns alongside their ...